Morphine

Jump to: navigation, search

Synonyms / Brand Names: (-)-Heroin hydrochloride, (-)-Morphine, D-(-)-Morphine, Diacetylmorphine hydrochloride, Diamorphine hydrochloride, Heroin hydrochloride, Heroine hydrochloride, Morphine Sulfate, Morphinum, O,O'-Diacetylmorphine hydrochloride, Morphin, Morphina, morphine, Apokyn, Astramorph PF, Avinza, Depodur, Dulcontin, Duramorph PF, Duromorph, Epimorph, Kadian, M-Eslon, M.O.S, MS/L MS/S, MSIR, Meconium, Morfina, Morphia, Morphine Extra-Forte, Morphine Forte, Morphine H.P, Morphinism, Morphitec, Morphium, Moscontin, Ms Contin, Nepenthe, OMS Concentrate, Oramorph SR, Ospalivina, RMS Uniserts, Rescudose, Roxanol, Roxanol 100, Roxanol UD, Statex, Statex Drops, l-Morphine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Intravenous Adult Dosage
The usual dose for administration to adults, via a compatible Hospira infusion device, is a 1 mg bolus, with a range of 0.2 to 3 mg per incremental dose for the 0.5 mg/mL and 1 mg/mL concentrations and a range of 0.5 to 3 mg per incremental dose for the 5 mg/mL concentration. The recommended Lockout Interval is 6 minutes. The physician may adjust the dosage either upward or downward; depending on patient response. Occasionally, it may be necessary to exceed the usual dosage in cases of exceptionally severe pain or in those patients who become tolerant.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Morphine

Return to top

Publication Resources

Most Recent Articles on Morphine

Review Articles on Morphine

Articles on Morphine in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Morphine

Return to top

Trial Resources

Ongoing Trials with Morphine at Clinical Trials.gov

Trial Results with Morphine

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Morphine

Cochrane Collaboration on Morphine

Cost Effectiveness of Morphine

Return to top

Media Resources

Powerpoint Slides on Morphine

Images of Morphine

Podcasts & MP3s on Morphine

Videos on Morphine

Return to top

Patient Resources

Patient Resources on Morphine

Discussion Groups on Morphine

Patient Handouts on Morphine

Blogs on Morphine

Morphine in the News

Morphine in the Marketplace

Return to top

International Resources

Morphine en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox